TD Cowen analyst Gary Taylor lowered the firm’s price target on Molina Healthcare (MOH) to $342 from $378 and keeps a Buy rating on the shares.

Molina Healthcare CEO Joseph Zubretsky downplayed GOP proposals to slash spending on Medicaid, which accounts for about 80% ...

Healthcare plan provider Molina Healthcare, Inc. MOH is set to report fourth-quarter 2024 results on Feb. 5, 2025, after the ...

Q4 2024 Earnings Call Transcript February 6, 2025 Jeffrey Geyer: Good day, and welcome to the Molina Healthcare Fourth ...

Molina Healthcare Inc (NYSE:MOH) is set to release its Q4 2024 earnings on Feb 5, 2025. The consensus estimate for Q4 2024 ...

Molina Healthcare, Inc. (NYSE:MOH – Get Free Report) gapped down before the market opened on Thursday following a ...

Molina Healthcare CEO Joe Zubretsky downplayed attempts by Republicans to gut or limit Medicaid in upcoming reconciliation ...

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on Molina Healthcare (MOH – Research Report) yesterday and set a ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Medicaid MCR is forecasted at 89.9% for 2025, with most rate increases already known. Medicare is expected to see a slightly elevated MCR above target due to utilization pressure and suboptimal recent ...

Molina Healthcare Inc. closed 32.77% short of its 52-week high of $423.92, which the company achieved on March 27th.